Search

Displaying results 41 - 50 of 9725 in total
  1. Drug

    Ubidecarenone

    go.drugbank.com/drugs/DB09270
    ApprovedInvestigationalNutraceutical

    [L1062] Ubidecarenone is sold as a dietary supplement and is not FDA approved as a drug - it is not meant to treat, cure or prevent any disease. … It is fundamental for cells that have a high metabolic demand.

    Mixtures: Co-q10 M.R.B. 100mg and Vitamin E, Co-q10 M.R.B. 60mgProducts: Nutri-chem Coenzyme Q10 20mg, Coenzyme Q10 Tab 10mg
  2. Drug

    Atorvastatin

    go.drugbank.com/drugs/DB01076
    ApprovedInvestigational

    Prescribing statins is considered standard practice for patients following any cardiovascular event, and for people who are at moderate to high risk of developing cardiovascular disease. … [T568] It is a pentasubstituted pyrrole [A177415] formed by two contrasting moieties with an achiral heterocyclic core unit and a 3,5-dihydroxypentanoyl side chain identical to its parent compound.

    Mixtures: ATOZET TABLET 10MG/40MG, CADUET TABLETS 10MG/40MGProducts: ATORVASTATIN CT 10MG FTA, ATORVASTATIN CT 20MG FTA
  3. Drug

    Pravastatin

    go.drugbank.com/drugs/DB00175
    ApprovedInvestigational

    [T303] Pravastatin was firstly approved in 1991 becoming the second available statin in the United States. It was the first statin administered as the active form and not as a prodrug. … [T274] This drug was developed by Sankyo Co. Ltd.; however, the first approved pravastatin product was developed by Bristol Myers Squibb and FDA approved in 1991.

    Mixtures: PRAVAFEN HARD CAPSULES 40mg/160mg, Pravafen 40mg/160mg Hard CapsulesProducts: PRAVASTATIN HEU 10MG NET, PRAVASTATIN - CT 10MG TABL
  4. Drug

    Desipramine

    go.drugbank.com/drugs/DB01151
    Approved

    Secondary amine TCAs, such as desipramine and nortriptyline, are more potent inhibitors of norepinephrine reuptake than tertiary amine TCAs, such as amitriptyline and doxepine. … Desipramine exerts less anticholinergic and sedative side effects compared to tertiary amine TCAs, such as amitriptyline and clomipramine.

    Products: PMS Desipramine Hydro Tab 10mg, Norpramin 10mg Tab
  5. Drug

    Aripiprazole

    go.drugbank.com/drugs/DB01238
    ApprovedInvestigational

    [L45859] It is also indicated as an injection for agitation associated with schizophrenia or bipolar mania. … [L45859,A4393] Aripiprazole was given FDA approval on November 15, 2002.[L6136]

    Products: ARIP MT 10 TABLETS 10mg, ARIP MT 15 TABLETS 15mg
  6. Drug

    Trospium

    go.drugbank.com/drugs/DB00209
    ApprovedInvestigational

    ._ and was granted FDA approval in 2007.[L6211]

    Products: SPASMOLYT 10MG, SPASMED 15MG FTA
  7. Drug

    Nifedipine

    go.drugbank.com/drugs/DB01115
    ApprovedInvestigational

    [A190273] Nifedipine was granted FDA approval on 31 December 1981.[L11383] … [A190210,A190273,A175390,L11383] Nifedipine was developed by Bayer and first described in the literature, along with other dihydropyridines, in 1972.

    Products: Adalat Pa 10 Tab 10mg, Nifedipine Pa 10 - Srt 10mg
  8. Drug

    Flupentixol

    go.drugbank.com/drugs/DB00875
    ApprovedInvestigationalWithdrawn

    [L31808] It has been marketed to manage symptoms of depression in patients who may or may not exhibit signs of anxiety. … It exists in two geometric isomers, the trans(E) and pharmacologically active cis(Z) forms.

    Products: FLUANXOL DEPOT2%10MG/0.5ML, FLUPENTIXOL-NEURAX 40MG/ML
  9. Drug

    Temazepam

    go.drugbank.com/drugs/DB00231
    Approved

    In particular, before temazepam saw regular prescription use in civilians it was - and still is - employed by the US military as a sedative-hypnotic medication to be taken by soldiers, pilots, etc. to … Although the chemical synthesis of temazepam was established by 1965 [A175333], mainstream contemporary use of the medication did not occur until it's legitimate use as treatment for insomnia was accepted

    Products: PMS-temazepam - 15mg, REMESTAN MITE 10MG
  10. Drug

    Promethazine

    go.drugbank.com/drugs/DB01069
    ApprovedInvestigational

    Promethazine, originally known as 3,277 R.P., is an N-dimethylaminopropyl derivative of [phenothiazine] that was developed in France in 1946. … [A189901] Promethazine antagonizes a variety of receptors, allowing it to be used for a number of indications including allergic reactions, pain, sedation, nausea, and vomiting.

    Mixtures: COPHADYL-E COUGH LINCTUSCategories: Antihistamines, Anesthetics, Etc.